Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Zhonghua Yi Xue Za Zhi|December 24, 2013
[Surgical treatment of hemangioblastoma in medulla oblongata:a report of 12 cases]Yong Yan, Ju-xiang Chen, Yi-cheng Lu, et al.Carcinogenesis|January 22, 2014
Ubiquitin-specific protease 2a stabilizes MDM4 and facilitates the p53-mediated intrinsic apoptotic pathway in glioblastomaChun-Lin Wang, Jun-Yu Wang, Zhen-Yang Liu, et al.Frontiers in Endocrinology|February 6, 2023
Association between growth differentiation factor 15 levels and gestational diabetes mellitus: A combined analysisYi-Cheng Lu, Song-Liang Liu, Yu-Shan Zhang, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 17, 2024
Telemedicine facilitates medical care for hospitalized patients in quarantineTung-Hung Su, Yi-Cheng Lu, Jia-Wei Li, et al.Oncology Reports|June 28, 2012
Knockdown of CDK6 enhances glioma sensitivity to chemotherapyBing Li, Hua He, Bang-Bao Tao, et al.American Journal of Cancer Research|July 10, 2023
High PIVKA-II level and ASAP score predict 1-year risk of hepatocellular carcinoma in non-cirrhotic chronic hepatitis B patientsYi-Cheng Lu, Tung-Hung Su, Tai-Chung Tseng, et al.Zhonghua Yi Xue Za Zhi|June 20, 2009
[Microsurgical strategies of glioma located in lateral fissure area]Ju-xiang Chen, Yi-cheng Lu, Chun-lin Wang, et al.Polymers|April 12, 2019
Antibacterial Property and Cytotoxicity of a Poly(lactic acid)/Nanosilver-Doped Multiwall Carbon Nanotube NanocompositeChi-Hui Tsou, Wei-Hua Yao, Yi-Cheng Lu, et al.Biochemical and Biophysical Research Communications|April 3, 2014
Higher LRRFIP1 expression in glioblastoma multiforme is associated with better response to teniposide, a type II topoisomerase inhibitorWei-Qing Li, Hong-Yu Yu, Yi-Ming Li, et al.Neuro-Oncology|April 24, 2016
Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cellsPítia F Ledur, Chong Liu, Hua He, et al.Pageof 7